Center for Scientific Review; Notice of Closed Meetings, 14930 [06-2886]
Download as PDF
<![CDATA[
14930
Federal Register / Vol. 71, No. 57 / Friday, March 24, 2006 / Notices
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 20, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–2887 Filed 3–23–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
wwhite on PROD1PC61 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Stem Cell
Selection.
Date: March 29, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Richard Panniers, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212,
MSC 7890, Bethesda, MD 20892. (301) 435–
1741. pannierr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDSassociated Malignancies.
Date: April 6, 2006.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892. (301) 435–
1167. srinivar@csr.nih.gov.
VerDate Aug<31>2005
18:26 Mar 23, 2006
Jkt 208001
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AIDS—
Molecular and Cell Biology.
Date: April 7, 2006.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892. (301) 435–
1167. srinivar@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Treatment
Technologies.
Date: April 14, 2006.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Lee Rosen, PhD, Scientific
Review Administrator, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 5116, MSC 7854,
Bethesda, MD 20892. (301) 435–1171.
rosenl@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 19, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–2886 Filed 3–23–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Office of the Secretary
Critical Infrastructure Partnership
Advisory Council
Preparedness Directorate,
Office of Infrastructure Protection,
Department of Homeland Security.
ACTION: Committee management: notice
of committee establishment.
AGENCY:
SUMMARY: In order to facilitate an
effective defense of our Nation’s critical
infrastructure, the Department of
Homeland Security is creating the
Critical Infrastructure Partnership
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
Advisory Council. Pursuant to the
Homeland Security Act of 2002, the
Department is taking measures to
facilitate strategic planning and effective
discussion of critical infrastructure
issues and to protect sensitive critical
infrastructure information while also
observing appropriate public disclosure
procedures for the council.
Name of Committee: Critical
Infrastructure Partnership Advisory
Council (CIPAC).
FOR FURTHER INFORMATION CONTACT:
Brett Lambo, Infrastructure Programs
Office, Infrastructure Partnerships
Division, Office of Infrastructure
Protection, Preparedness Directorate,
United States Department of Homeland
Security, Washington, DC 20528,
telephone (703) 235–5311 or via e-mail
at brett.lambo@dhs.gov.
SUPPLEMENTARY INFORMATION:
Background
1. The Department’s Relationship With
Owners of Critical Infrastructure
Approximately 85 percent of this
nation’s critical infrastructure is owned
by the private sector. See, e.g., National
Infrastructure Advisory Council Report,
Sector Partnership Model
Implementation: Final Report and
Recommendations 6 (Oct. 11, 2005)
(‘‘NIAC Report’’). Thus, in drafting the
Homeland Security Act of 2002,
Congress repeatedly stressed that the
new Department of Homeland Security
must have a close and highly effective
relationship with the private sector
owners of this infrastructure. See, e.g.,
6 U.S.C. 121(d)(11) (requiring
consultation with ‘‘private sector
entities to ensure appropriate exchanges
of information’’); 6 U.S.C. 112(c)
(requiring coordination with non-federal
entities); see also Statement of Senator
Joe Lieberman, Nov. 16, 2005 (‘‘That’s
why we created an Infrastructure
Protection division in the Department of
Homeland Security which was the first
of its kind at any federal agency. The
point was that government needed to
work with the private sector to make
sure the systems so crucial to our way
of life were adequately protected, and if
attacked by terrorists or overwhelmed
by natural forces, were able to recover
quickly and restore services.’’).
Congress explicitly instructed the
Department to create an effective
structure for sharing sensitive
information with the private sector on
infrastructure. Congress also explicitly
mandated that the Department ‘‘ensure
the security and confidentiality’’ of
sensitive homeland security
information, and gave the Department
specific new authorities to protect such
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 71, Number 57 (Friday, March 24, 2006)]
[Notices]
[Page 14930]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2886]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Stem Cell Selection.
Date: March 29, 2006.
Time: 2 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Richard Panniers, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2212, MSC 7890, Bethesda, MD
20892. (301) 435-1741. pannierr@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AIDS-associated Malignancies.
Date: April 6, 2006.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892. (301) 435-1167. srinivar@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AIDS--Molecular and Cell Biology.
Date: April 7, 2006.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Ranga V. Srinivas, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222, MSC 7852, Bethesda, MD
20892. (301) 435-1167. srinivar@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Treatment Technologies.
Date: April 14, 2006.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Lee Rosen, PhD, Scientific Review Administrator,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5116, MSC 7854, Bethesda, MD 20892. (301) 435-
1171. rosenl@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 19, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-2886 Filed 3-23-06; 8:45 am]
BILLING CODE 4140-01-M
